Approximately 18.2 million adults aged 20 and above suffer from coronary artery disease. Acute coronary syndrome, including non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI), is caused by a sudden blockage in the heart's blood supply. There have been significant advancements in diagnosing and treating NSTEMI and STEMI in recent years. Triple vessel disease (TAD) is also considered a life-threatening form of CAD and the treatment choices are still a point of concern. To understand the management strategies for different types of CADs, we have organized a webinar in association with CIMS on 16th September 2021, 3 PM onwards.
Session highlights 1. A case of STEMI (Post Thrombolysis) with TVD - What is the ideal management 2. NSTEMI - Diagnosis & management - What's new in 2021 3. FFRCT for decision making in…
